Next Article in Journal
Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?
Next Article in Special Issue
The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies
Previous Article in Journal
Implication of miR-126 and miR-139-5p in Plasmacytoid Dendritic Cell Dysregulation in Systemic Sclerosis
Previous Article in Special Issue
Molecular and Metabolic Subtypes Correspondence for Pancreatic Ductal Adenocarcinoma Classification
 
 
Article

Article Versions Notes

J. Clin. Med. 2021, 10(3), 490; https://doi.org/10.3390/jcm10030490
Action Date Notes Link
article pdf uploaded. 30 January 2021 13:30 CET Version of Record https://www.mdpi.com/2077-0383/10/3/490/pdf-vor
article xml file uploaded 1 February 2021 07:45 CET Original file -
article xml uploaded. 1 February 2021 07:45 CET Update -
article pdf uploaded. 1 February 2021 07:45 CET Updated version of record https://www.mdpi.com/2077-0383/10/3/490/pdf-vor
article supplementary file uploaded. 1 February 2021 07:45 CET - https://www.mdpi.com/2077-0383/10/3/490#supplementary
article html file updated 1 February 2021 07:46 CET Original file -
article xml file uploaded 3 February 2021 08:45 CET Update -
article xml uploaded. 3 February 2021 08:45 CET Update https://www.mdpi.com/2077-0383/10/3/490/xml
article pdf uploaded. 3 February 2021 08:45 CET Updated version of record https://www.mdpi.com/2077-0383/10/3/490/pdf
article html file updated 3 February 2021 08:47 CET Update -
article html file updated 24 July 2022 08:07 CEST Update https://www.mdpi.com/2077-0383/10/3/490/html
Back to TopTop